No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19

BACKGROUND: The use of hydroxychloroquine (HCQ), with or without concurrent administration of azithromycin (AZM), for treatment of COVID-19 has received considerable attention. The purpose of this study was to determine whether HCQ administration is associated with improved mortality in COVID-19 pat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Infect Dis
Main Authors: Sands, Kenneth, Wenzel, Richard, McLean, Laura, Korwek, Kimberly, Roach, Jonathon, Miller, Karla, Poland, Russell E., Burgess, L. Hayley, Jackson, Edmund, Perlin, Jonathan B.
Formato: Artigo
Idioma:Inglês
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7834474/
https://ncbi.nlm.nih.gov/pubmed/33359949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2020.12.060
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares